# Serum and Cellular Biomarkers for Aortic Valve Stenosis

> **NCT04312139** · — · UNKNOWN · sponsor: **National and Kapodistrian University of Athens** · enrollment: 280 (estimated)

## Conditions studied

- Calcific Aortic Valve Disease
- Aortic Valve Stenosis
- Aortic Valve, Calcification of

## Interventions

- **DIAGNOSTIC_TEST:** Echocardiography
- **DIAGNOSTIC_TEST:** Computerized Tomography Aortic Valve Calcium Score
- **OTHER:** Untargeted LC/MS and LC-MS/MS
- **OTHER:** Targeted LC/MS and LC-MS/MS
- **DIAGNOSTIC_TEST:** multiplex ELISA

## Key facts

- **NCT ID:** NCT04312139
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2025-03
- **Final completion:** 2025-09
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2022-10-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04312139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04312139, "Serum and Cellular Biomarkers for Aortic Valve Stenosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04312139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*